Keyphrases
Perforator
100%
Flap
92%
Anatomical Study
76%
Breast Reconstruction
69%
Cyanoacrylate
64%
Synthetic Adhesive
51%
Sutureless
51%
Donor Site
43%
Butyl Cyanoacrylate
38%
Gastric Closure
38%
Gastrotomy Closure
38%
Tissue Glue
38%
Flexible Tissues
38%
Clinical Feasibility
38%
N-butyl Cyanoacrylate
38%
DIEP Flap
38%
Indocyanine Green Angiography
38%
Immediate Breast Reconstruction
38%
Thoracodorsal Artery Perforator Flap (TAP flap)
38%
Flap Perfusion
38%
Recipient Site
38%
Imprint Cytology
38%
Liberase
38%
Softener
38%
Collagenase
38%
Engraftment
38%
Histoacryl
38%
Intraoperative Assessment
38%
Radiological Assessment
38%
Diabetic Rats
38%
Islet
38%
Sentinel Lymph Node
38%
Breast Carcinoma
38%
Clinical Application
38%
Histologic
38%
Intercostal Artery
38%
Perfusion
30%
Intercostal Perforator Flap
29%
BREAST-Q
25%
Serial Sectioning
25%
Axillary Lymph Node Dissection
25%
Resection
25%
Sentinel Lymph Node Biopsy
25%
Micrometastasis
25%
Closure Technique
25%
Hand-sewn
25%
Hematological Markers
25%
Inflammatory Biomarkers
25%
Hollow Viscus
25%
Interrupted Suture
25%
Medicine and Dentistry
Breast Reconstruction
84%
Enbucrilate
76%
Perforator Flap
76%
Intercostal Arteries
76%
Cyanoacrylate Derivative
64%
Adhesive Agent
51%
Gastrotomy
44%
Suture
44%
Liberase
38%
Cytotechnology
38%
Deep Inferior Epigastric Perforator Flap
38%
Indocyanine Green Angiography
38%
Tissue Adhesive
38%
Breast Carcinoma
38%
Radiologic Studies
38%
Diabetes Mellitus
38%
Engraftment
38%
Sentinel Lymph Node
38%
Collagenase
38%
Operation Duration
20%
Cytokeratin
19%
Axillary Lymph Node
19%
Retroperitoneal Lymph Node Dissection
19%
Sentinel Lymph Node Biopsy
19%
Micrometastasis
19%
Viscera
19%
Biological Marker
19%
Quadrantectomy
15%
Vascularity
15%
Computed Tomography Angiography
15%
Cadaver
15%
Donor Site
15%
Cyanoacrylate
12%
Surgical Anastomosis
12%
Gastrostomy
12%
Flexibility
12%
Hyperbarism
12%
Incision
12%
Digestive System
12%
Endotoxin
10%
Islet Transplantation
10%
Cytokine Production
10%
Inflammatory Cytokine
10%
Immunohistochemistry
9%
Giemsa Stain
9%
Reoperation
9%
Paraffin Embedding
9%
Malignant Neoplasm
9%
Haematoxylin
9%
Eosin
9%